GERON CORP Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GERON CORP stock issued during period, value, new issues for the quarter ending 2021-03-31 was $16.23M, a 2266.47% increase year-over-year.
- GERON CORP stock issued during period, value, new issues for the quarter ending 2020-06-30 was $3.39M, a 3255.45% increase year-over-year.
- GERON CORP stock issued during period, value, new issues for the quarter ending 2020-03-31 was $686.00K.
- GERON CORP stock issued during period, value, new issues for the quarter ending 2019-09-30 was $8.96M, a 315.15% increase year-over-year.
- GERON CORP stock issued during period, value, new issues for fiscal 2021 was $20.39M, a 400.25% increase from fiscal 2020.
- GERON CORP stock issued during period, value, new issues for fiscal 2020 was $4.08M, a 78.88% decline from fiscal 2019.
- GERON CORP stock issued during period, value, new issues for fiscal 2019 was $19.30M, a 77.57% decline from fiscal 2018.
- GERON CORP stock issued during period, value, new issues for fiscal 2018 was $86.02M, a 8014.81% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $20.39M 10-K · filed 2024-02-28 | |
| 2021-03-31 | $16.23M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $4.08M 10-K · filed 2023-03-16 | |
| 2020-06-30 | $3.39M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $686.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $19.30M 10-K · filed 2022-03-10 | |
| 2019-09-30 | $8.96M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $101.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $86.02M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $2.16M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $82.31M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $1.55M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $1.06M 10-K · filed 2020-03-12 | |
| 2014-12-31 | $96.81M 10-K · filed 2017-03-01 | |
| 2010-12-31 | $93.70M 10-K · filed 2013-03-15 | |
| 2009-12-31 | $45.93M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |